Overview

Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese Volunteer

Status:
Completed
Trial end date:
2019-04-24
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare pharmacokinetic of Lansoprazole Capsules 30 mg with Lansoprazole Capsules of Takeda 30 mg in healthy adult human subjects.
Phase:
Phase 1
Details
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Collaborator:
Beijing Xuze Medical Technology Co., LTD.
Treatments:
Dexlansoprazole
Lansoprazole